Ticker > Company >

Phaarmasia share price

Phaarmasia Ltd.

BSE: 523620 SECTOR: Pharmaceuticals & Drugs  6171   9   0

50.00
-2.50 (-4.76%)
BSE: 07 Nov 04:01 PM

Price Summary

Today's High

₹ 52.6

Today's Low

₹ 50

52 Week High

₹ 64.75

52 Week Low

₹ 24.5

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

34.13 Cr.

Enterprise Value

33.5 Cr.

No. of Shares

0.68 Cr.

P/E

0

P/B

6

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  8.34

CASH

0.63 Cr.

DEBT

0 Cr.

Promoter Holding

73.51 %

EPS (TTM)

₹  -0.67

Sales Growth

11.29%

ROE

-8.21 %

ROCE

-7.95%

Profit Growth

58.85 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year11.29%
3 Year15.42%
5 Year4.8%

Profit Growth

1 Year58.85%
3 Year-218.43%
5 Year-192.21%

ROE%

1 Year-8.21%
3 Year-14.56%
5 Year-6.85%

ROCE %

1 Year-7.95%
3 Year-15.06%
5 Year-5.77%

Debt/Equity

0

Price to Cash Flow

318.42

Interest Cover Ratio

-11.4351

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 73.51 0.00
Jun 2024 73.51 0.00
Mar 2024 73.51 0.00
Dec 2023 73.51 0.00
Sep 2023 73.51 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 15.4227920094447% for the Past 3 years.
  • The company has significantly decreased its debt by 0.0063 Cr.
  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of -185.2378 days.
  • The company has a high promoter holding of 73.51%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 12.283001038434.

 Limitations

  • The company has shown a poor profit growth of -218.427881831404% for the Past 3 years.
  • Company has a poor ROE of -14.5567271901199% over the past 3 years.
  • Company has a poor ROCE of -15.0622614451132% over the past 3 years
  • The company has a low EBITDA margin of -3.06717064811998% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 8.65 5.08 9.99 8.29 5.93
Total Expenditure 8.92 5.64 9.66 8.11 6.71
Operating Profit -0.27 -0.56 0.33 0.18 -0.79
Other Income 0.2 0.13 0.2 0.15 0.23
Interest 0.01 0.03 0.01 0 0
Depreciation 0.09 0.08 0.09 0.08 0.08
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.17 -0.54 0.44 0.25 -0.65
Tax -0.01 0.02 -0.04 -0.03 0
Profit After Tax -0.16 -0.57 0.47 0.28 -0.64
Adjusted EPS (Rs) -0.24 -0.83 0.69 0.41 -0.94

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 24.45 19.9 17.22 27.49 30.59
Total Expenditure 23.63 19.96 18.95 29.03 31.41
Operating Profit 0.82 -0.06 -1.74 -1.54 -0.82
Other Income 0.58 0.89 0.47 0.52 0.66
Interest 0.04 0.01 0 0.04 0.04
Depreciation 0.4 0.34 0.29 0.36 0.34
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.96 0.48 -1.56 -1.43 -0.55
Tax 0.42 0.17 -0.02 -0.17 -0.03
Net Profit 0.54 0.31 -1.55 -1.26 -0.52
Adjusted EPS (Rs.) 0.79 0.46 -2.27 -1.84 -0.76

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 6.83 6.83 6.83 6.83 6.83
Total Reserves 6.58 6.83 5.23 3.98 3.47
Borrowings 0.03 0.02 0.01 0.01 0
Other N/C liabilities 0.72 0.36 0.26 0.27 0.15
Current liabilities 19.43 7.88 8.88 17.28 20.91
Total Liabilities 33.6 21.91 21.21 28.37 31.37
Assets
Net Block 13.4 13.06 12.76 12.79 12.48
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0.26 0.26 0.14 0.54 0.92
Other N/C Assets 0 0 0 0 0
Current Assets 19.94 8.59 8.3 15.04 17.97
Total Assets 33.6 21.91 21.21 28.37 31.37
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 0.96 0.48 -1.56 -1.43 -0.55
Adjustment 0.47 0.25 0.24 0.38 0.35
Changes in Assets & Liabilities -1.09 -0.24 1.32 1.71 0.3
Tax Paid -0.26 -0.24 -0.17 0 0
Operating Cash Flow 0.08 0.25 -0.18 0.65 0.11
Investing Cash Flow 0 0 0.01 -0.01 0
Financing Cash Flow -0.11 -0.02 0 -0.16 -0.16
Net Cash Flow -0.03 0.23 -0.17 0.48 -0.06

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 73.51 73.51 73.51 73.51 73.51
maneesh pharmaceuticals l... 44.22 44.22 44.22 44.22 44.22
svizera labs pvt ltd 29.30 29.30 29.30 29.30 29.30
PARTICULARS Sep 2019% Mar 2020% Mar 2024% Jun 2024% Sep 2024%
investors 26.55 26.55 26.49 26.49 26.49
amruta nishant kalsekar - - - 1.49 1.49
madhavi pradeep save - - - 1.73 1.73
vittal rao lakkaraju - - 3.22 - -
non-resident indian (nri)... - 0.07 - - -
vithal rao l v 1.10 - - - -

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Phaarmasia - Quaterly Results 5 Nov, 5:58 PM Phaarmasia - Quaterly Results 5 Nov, 5:58 PM Phaarmasia informs about compliance certificate 15 Oct, 4:48 PM Phaarmasia informs about press release 13 Aug, 2:52 PM Phaarmasia - Quaterly Results 12 Aug, 4:27 PM Phaarmasia - Quaterly Results 12 Aug, 4:27 PM Phaarmasia - Quaterly Results 12 Aug, 4:27 PM Phaarmasia - Quaterly Results 25 May, 4:55 PM Phaarmasia - Quaterly Results 25 May, 4:55 PM Phaarmasia - Quaterly Results 25 May, 4:55 PM Phaarmasia informs about closure of trading window 30 Mar, 12:55 PM Phaarmasia informs about closure of trading window 30 Mar, 11:53 AM Phaarmasia - Quaterly Results 13 Feb, 12:55 PM Phaarmasia - Quaterly Results 13 Feb, 12:55 PM Phaarmasia - Quaterly Results 13 Feb, 12:55 PM Phaarmasia informs about issuance of duplicate share certificate 25 Jan, 12:10 PM Phaarmasia - Quaterly Results 14 Aug, 3:30 PM Phaarmasia informs about AGM 6 Jul, 12:57 PM Phaarmasia - Quaterly Results 25 May, 3:48 PM Phaarmasia - Quaterly Results 25 May, 3:48 PM Phaarmasia - Quaterly Results 25 May, 3:48 PM Phaarmasia informs about RTA certificate 24 Apr, 2:53 PM Phaarmasia submits post-offer public announcement 23 Feb, 4:18 PM Phaarmasia - Quaterly Results 13 Feb, 1:46 PM Phaarmasia - Quaterly Results 13 Feb, 1:46 PM Phaarmasia - Quaterly Results 13 Feb, 1:46 PM Phaarmasia informs about offer letter 9 Feb, 3:40 PM Phaarmasia informs about trading window closure 31 Dec, 3:21 PM Phaarmasia informs about disclosure 11 Nov, 4:57 PM Phaarmasia submits certificate 29 Apr, 5:34 PM Phaarmasia - Quaterly Results 10 Feb, 4:49 PM Phaarmasia - Quaterly Results 10 Feb, 4:49 PM Phaarmasia informs about voting results 25 Sep, 2:41 PM Phaarmasia informs about board meeting 5 Feb, 3:39 PM

Phaarmasia Stock Price Analysis and Quick Research Report. Is Phaarmasia an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Phaarmasia and its performance over the period of time. Phaarmasia stock price today is Rs 50.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Phaarmasia cash from the operating activity was Rs 0.1072 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Phaarmasia has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Phaarmasia , the EPS growth was 58.8484 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Phaarmasia has OPM of -2.6790179549117 % which is a bad sign for profitability.
     
  • ROE: Phaarmasia have a poor ROE of -8.2079 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Phaarmasia is Rs 50. One can use valuation calculators of ticker to know if Phaarmasia share price is undervalued or overvalued.
Last Updated on:
Brief about Phaarmasia
X